Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

14/10 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
01/26/01	€0.6800	-2.02%	26,001
30/26/30	€0.6940	-0.86%	26,494
29/26/29	€0.7000	-2.37%	54,037
28/26/28	€0.7170	-4.40%	42,625
25/26/25	€0.7500	+9.97%	2,41,869

Real-time Euronext Paris

More quotes

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris 09:25:00 01/10/2026 pm IST			5-day change	1st Jan Change
0.6800 ^EUR	-2.02%		-0.29%	+12.96%

17/09	Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
16/09	Theraclion widens its operating loss in the first half

Market Cap	5.07Cr 5.71Cr 4.74Cr 4.32Cr 8.14Cr 549.99Cr 8.25Cr 57Cr 22Cr 280.1Cr 21Cr 21Cr 899.66Cr	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	5.86Cr 6.6Cr 5.48Cr 4.99Cr 9.4Cr 635.11Cr 9.53Cr 66Cr 26Cr 323.45Cr 25Cr 24Cr 1.04TCr	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	32.52%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALTHE	Real-time
Börse Stuttgart	941	Delayed
CBOE		Real-time
Boerse Muenchen	941	Real-time
Deutsche Boerse AG	941	Delayed
CBOE		Real-time

17/09	Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
16/09	Theraclion widens its operating loss in the first half
24/07	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
09/07	Theraclion Announces Board Changes	CI
09/07	Theraclion Appoints New Chairman	MT
19/06	Claude Lenoir appointed interim chairman of Theraclion
19/06	Theraclion Chairman Steps Down; Interim Successor Named	MT
18/06	Theraclion Announces Board Changes	CI
09/06	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
05/06	Theraclion deploys first Sonovein system in China
05/06	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
05/06	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
05/06	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI

Theraclion Share Price

Stocks

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news: Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Price Extremes

Managers and Directors: Theraclion

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

16/09	2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development	BU
23/07	Theraclion Initiates Its Commercial Momentum in the First Half of 2026	BU
15/07	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
09/07	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
18/06	Theraclion Announces the Evolution of Its Board of Directors	BU

16/09	Theraclion creuse sa perte d'exploitation au 1er semestre
16/09	RÉSULTATS SEMESTRIELS 2026 : THERACLION SE PRÉPARE À UNE NOUVELLE ÉTAPE DE SON DÉVELOPPEMENT
23/07	THERACLION AMORCE SA DYNAMIQUE COMMERCIALE AU PREMIER SEMESTRE 2026
15/07	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
09/07	Vincent Gardès prend la présidence du conseil d'administration de Theraclion

1 day	-2.02%
1 week	-0.29%
Current month	-2.02%
1 month	-11.69%
3 months	+1.04%
6 months	+54.55%
Current year	+12.96%

1 week	0.67	0.76
1 month	0.63	0.76
Current year	0.4	0.93
1 year	0.4	0.93
3 years	0.14	1.25
5 years	0.14	1.9
10 years	0.14	6.3

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Mehdi El Glaoui BRD	Director/Board Member	-	22/06/2021
Cédric Bellanger BRD	Director/Board Member	-	28/01/2022
Lijuan Deng BRD	Director/Board Member	-	29/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	-2.02%	-0.29%	-8.11%	+19.30%	5.76Cr
THERMO FISHER SCIENTIFIC, INC.	-2.80%	-3.18%	+23.75%	+32.48%	25TCr
DANAHER CORPORATION	-3.96%	-4.66%	+0.22%	-0.18%	16TCr
INTUITIVE SURGICAL, INC.	-1.71%	+0.73%	-8.13%	+36.43%	14TCr
BOSTON SCIENTIFIC CORPORATION	-1.23%	-3.13%	-54.85%	-18.05%	6.33TCr
EDWARDS LIFESCIENCES CORPORATION	-1.87%	-0.96%	+11.27%	+22.74%	4.98TCr
AGILENT TECHNOLOGIES, INC.	-2.71%	-3.05%	+20.92%	+51.10%	4.86TCr
SIEMENS HEALTHINEERS AG	-0.95%	+1.07%	-18.77%	-21.76%	4.8TCr
VEEVA SYSTEMS INC.	-0.54%	+3.62%	-2.89%	+41.56%	4.62TCr
WATERS CORPORATION	-2.54%	-0.36%	+34.06%	+58.49%	4.32TCr
Average	-2.06%	+2.18%	-0.25%	+22.21%	8.48TCr
Weighted average by Cap.	-2.42%	+2.37%	+3.94%	+22.62%

	2024	2025
Net sales	8L 9L 8L 7L 13.32L 9Cr 13.5L 93.92L 36.36L 4.58Cr 35.09L 34.33L 15Cr	7L 7L 6L 6L 10.46L 7.07Cr 10.6L 73.76L 28.55L 3.6Cr 27.56L 26.96L 12Cr
Net income	-57.57L -64.82L -53.84L -49.06L -92.37L -62Cr -93.64L -6.51Cr -2.52Cr -32Cr -2.43Cr -2.38Cr -102.08Cr	-56.9L -64.06L -53.21L -48.49L -91.29L -62Cr -92.54L -6.44Cr -2.49Cr -31Cr -2.41Cr -2.35Cr -100.89Cr
Net Debt	34.11L 38.4L 31.9L 29.07L 54.72L 37Cr 55.47L 3.86Cr 1.49Cr 19Cr 1.44Cr 1.41Cr 60Cr	78.52L 88.4L 73.43L 66.91L 1.26Cr 85Cr 1.28Cr 8.88Cr 3.44Cr 43Cr 3.32Cr 3.25Cr 139.23Cr